top of page

Anavex President & CEO Christopher U. Missling, PhD, to Participate in a Roundtable Discussion

  • Writer: ANAVEX® Life Sciences Corp.
    ANAVEX® Life Sciences Corp.
  • Apr 21, 2017
  • 1 min read

Anavex President & CEO Christopher U. Missling, PhD, to participate in a roundtable discussion at the World Orphan Drug Congress USA, Friday, at 12:20 PM on April 21.


Wardmar Park Marriott Washington, DC


Roundtable 4: Partnerships- successful collaboration between a rare disease foundation and a pharmaceutical company to advance preclinical and clinical research in Rett Syndrome.

 
 
bottom of page